Design
The study design was a 2-arm randomized clinical trial with participants allocated to either the experimental condition or the waitlist control condition. Eligibility requirements were (1) age between 18 and 25 years; (2) a score of at least 10 on the Patient Health Questionnaire–9 (PHQ-9) [